Nigerian pharma tycoon Fidelis Ayebae’s stake in Fidson is now worth $14.8 million
Under Ayebae’s guidance, Fidson Healthcare has achieved exceptional financial growth, reporting a significant increase in profits for the 2022 fiscal year.
Fidson
Skip to content
Under Ayebae’s guidance, Fidson Healthcare has achieved exceptional financial growth, reporting a significant increase in profits for the 2022 fiscal year.